Skip to content
value.today

Modernizing Medicine Inc.

Total raised
$249 M
5 rounds on record
Latest round
$206 M
May 2017
First round on record
Feb 2011
Today
Private
No later event on record

Funding rounds

5 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Modernizing Medicine Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2022$53 MIssued in a merger or acquisition$50 to $250 million

Modernizing Medicine Inc.: Private sale, Feb 2022

Investors in this round

38 investors had bought by the notice of Feb 22, 2022: 38 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$53 M of $53 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Cane · Executive Officer, Director
  • Joseph Harpaz · Executive Officer
  • Mark Fleisher · Executive Officer
  • Michael Sherling · Executive Officer, Director
  • Michelle Scheer · Executive Officer
  • Amr Kronfol · Director
  • Andrew Park · Director
  • Barry Mosheim · Director
  • Gary Steele · Director
  • Gina Loften · Director
  • Jean Bua · Director
  • Phillip Pead · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Fleisher, Senior Executive Vice President and General Counsel. Source: SEC Form D, newest notice filed Feb 22, 2022. Read the notice at the SEC.

equitySEC
May 2017$206 MNo. 5$50 to $250 million

Modernizing Medicine Inc.: Raise no. 5, May 2017

Investors in this round

6 investors had bought by the notice of May 22, 2017: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$206 M of $231 M offered; $25 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Cane · Executive Officer, Director
  • Karen O'Byrne · Executive Officer
  • Mark Fleisher · Executive Officer
  • Michael Sherling · Executive Officer, Director
  • Rick Von Pusch · Executive Officer
  • Amr Kronfol · Director
  • Barry Mosheim · Director
  • Fred Hassan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Fleisher, Senior Executive Vice President and General Counsel. Source: SEC Form D, newest notice filed May 22, 2017. Read the notice at the SEC.

equity, optionsSEC
Sep 2015$38 MIssued in a merger or acquisition$10 to $50 million

Modernizing Medicine Inc.: Private sale, Sep 2015

Investors in this round

7 investors had bought by the notice of Sep 15, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$38 M of $38 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Cane · Executive Officer, Director
  • Karen O'Byrne · Executive Officer
  • Mark Fleisher · Executive Officer
  • Michael Sherling · Executive Officer, Director
  • Barry Mosheim · Director
  • Mark deLaar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Fleisher, Senior Executive Vice President and General Counsel. Source: SEC Form D, newest notice filed Sep 15, 2015. Read the notice at the SEC.

equity, optionsSEC
Nov 2014$16 MNo. 4$10 to $50 million

Modernizing Medicine Inc.: Raise no. 4, Nov 2014

Investors in this round

60 investors had bought by the notice of Nov 12, 2014: 60 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $20 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brad Rennick · Executive Officer
  • Daniel Cane · Executive Officer, Director
  • Karen O'Byrne · Executive Officer
  • Mark Fleisher · Executive Officer
  • Michael Sherling · Executive Officer, Director
  • Patric Edmondson · Executive Officer
  • Barry Mosheim · Director
  • Mark deLaar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Fleisher, Senior Executive Vice President and General Counsel. Source: SEC Form D, newest notice filed Nov 12, 2014. Read the notice at the SEC.

equity, optionsSEC
Aug 2013$14 MNo. 3$10 to $50 million

Modernizing Medicine Inc.: Raise no. 3, Aug 2013

Investors in this round

4 investors had bought by the notice of Aug 20, 2013: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Cane · Executive Officer, Director
  • Karen O'Byrne · Executive Officer
  • Mark Fleisher · Executive Officer
  • Michael Sherling · Executive Officer, Director
  • Barry Mosheim · Director
  • Mark deLaar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Fleisher, Senior Executive Vice President and General Counsel. Source: SEC Form D, newest notice filed Aug 20, 2013. Read the notice at the SEC.

equity, optionsSEC
Jul 2012$7 MNo. 2$2 to $10 million

Modernizing Medicine Inc.: Raise no. 2, Jul 2012

Investors in this round

67 investors had bought by the notice of Jul 17, 2012: 67 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Cane · Executive Officer, Director
  • James Brooks · Executive Officer
  • Karen O'Byrne · Executive Officer
  • Mark Fleisher · Executive Officer
  • Michael Sherling · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Fleisher, Vice President and General Counsel. Source: SEC Form D, newest notice filed Jul 17, 2012. Read the notice at the SEC.

equity, optionsSEC
Feb 2011$7 MNo. 1$2 to $10 million

Modernizing Medicine Inc.: Raise no. 1, Feb 2011

Investors in this round

47 investors had bought by the notice of Mar 1, 2011: 47 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Cane · Director, Executive Officer
  • Michael Sherling, M.D. · Director, Executive Officer
  • Robert Nagro · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel Cane, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 1, 2011. Read the notice at the SEC.

equity, debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Modernizing Medicine Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2022).

    SEC Form D · Feb 2022

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Feb 2022

That is all the official record says: Modernizing Medicine Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Modernizing Medicine Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 67 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Modernizing Medicine Inc.
NameRoleNamed in
Daniel CaneExecutive officerFeb 2022
Joseph HarpazExecutive officerFeb 2022
Mark FleisherExecutive officerFeb 2022
Michael SherlingExecutive officerFeb 2022
Michelle ScheerExecutive officerFeb 2022
Karen O'ByrneExecutive officerMay 2017
Rick Von PuschExecutive officerMay 2017
Brad RennickExecutive officerNov 2014
Patric EdmondsonExecutive officerNov 2014
James BrooksExecutive officerJul 2012
Michael Sherling, M.D.Executive officerMar 2011
Robert NagroExecutive officerMar 2011
Amr KronfolDirectorFeb 2022
Andrew ParkDirectorFeb 2022
Barry MosheimDirectorFeb 2022
Daniel CaneDirectorFeb 2022
Gary SteeleDirectorFeb 2022
Gina LoftenDirectorFeb 2022
Jean BuaDirectorFeb 2022
Michael SherlingDirectorFeb 2022
Phillip PeadDirectorFeb 2022
Fred HassanDirectorMay 2017
Mark deLaarDirectorSep 2015
Michael Sherling, M.D.DirectorMar 2011